Bill Text: NY A00587 | 2017-2018 | General Assembly | Amended
Bill Title: Requires urine polymerase chain reaction testing for cytomegalovirus of newborns with hearing impairments; and directs the department of health to establish an education program for women who may become pregnant, expectant parents and parents of infants relating to various aspects of cytomegalovirus.
Spectrum: Moderate Partisan Bill (Democrat 24-4)
Status: (Passed) 2018-10-02 - signed chap.307 [A00587 Detail]
Download: New_York-2017-A00587-Amended.html
STATE OF NEW YORK ________________________________________________________________________ 587--C 2017-2018 Regular Sessions IN ASSEMBLY January 9, 2017 ___________ Introduced by M. of A. L. ROSENTHAL, ORTIZ, ZEBROWSKI, SANTABARBARA, GUNTHER, CARROLL, GALEF, NIOU, DINOWITZ, BLAKE, SEAWRIGHT, SOLAGES, HARRIS, JENNE, RAIA -- Multi-Sponsored by -- M. of A. BUCHWALD, ENGLE- BRIGHT, HYNDMAN, LUPARDO, McDONOUGH, NOLAN, SIMON, STECK, THIELE -- read once and referred to the Committee on Health -- committee discharged, bill amended, ordered reprinted as amended and recommitted to said committee -- recommitted to the Committee on Health in accord- ance with Assembly Rule 3, sec. 2 -- committee discharged, bill amended, ordered reprinted as amended and recommitted to said commit- tee -- again reported from said committee with amendments, ordered reprinted as amended and recommitted to said committee AN ACT to amend the public health law, in relation to the testing of certain newborns for cytomegalovirus and public education thereon The People of the State of New York, represented in Senate and Assem- bly, do enact as follows: 1 Section 1. Subdivision (a) of section 2500-a of the public health law, 2 as amended by chapter 184 of the laws of 2013, is amended to read as 3 follows: 4 (a) 1. It shall be the duty of the administrative officer or other 5 person in charge of each institution caring for infants twenty-eight 6 days or less of age and the person required in pursuance of the 7 provisions of section forty-one hundred thirty of this chapter to regis- 8 ter the birth of a child, to cause to have administered to every such 9 infant or child in its or his care a test for: 10 i. phenylketonuria, 11 ii. homozygous sickle cell disease, 12 iii. hypothyroidism, 13 iv. branched-chain ketonuria, 14 v. galactosemia, 15 vi. homocystinuria, EXPLANATION--Matter in italics (underscored) is new; matter in brackets [] is old law to be omitted. LBD01942-05-8A. 587--C 2 1 vii. critical congenital heart defects through pulse oximetry screen- 2 ing, [and] 3 viii. with regard to any newborn infant who is identified as, or 4 suspected of, having a hearing impairment as a result of a screening 5 conducted pursuant to section twenty-five hundred-g of this title, cause 6 to be administered to such infant a urine polymerase chain reaction 7 (PCR) test for cytomegalovirus, unless the parent of the infant objects 8 thereto; provided that if the commissioner determines that another test 9 for cytomegalovirus is diagnostically equivalent to or better than the 10 urine polymerase chain reaction test, the commissioner may, by regu- 11 lation under this section, allow or require the use of that other test, 12 and 13 ix. such other diseases and conditions as may from time to time be 14 designated by the commissioner in accordance with rules or regulations 15 prescribed by the commissioner. 16 2. Testing, the recording of the results of such tests, tracking, 17 follow-up reviews and educational activities shall be performed at such 18 times and in such manner as may be prescribed by the commissioner. The 19 commissioner shall promulgate regulations setting forth the manner in 20 which information describing the purposes of the requirements of this 21 section shall be disseminated to parents or a guardian of the infant 22 tested. 23 § 2. Subdivision 1 of section 207 of the public health law is amended 24 by adding a new paragraph (o) to read as follows: 25 (o) For women who may become pregnant, expectant parents and parents 26 of infants, information regarding: 27 (i) the incidence of cytomegalovirus; 28 (ii) the transmission and risks of cytomegalovirus to pregnant women 29 and women who may become pregnant; 30 (iii) birth defects caused by congenital cytomegalovirus; 31 (iv) methods of diagnosing congenital cytomegalovirus; 32 (v) the available preventive measures to avoid the infection of women 33 who are pregnant or may become pregnant; and 34 (vi) available methods of treating cytomegalovirus and resources 35 available for families of children born with cytomegalovirus. 36 § 3. This act shall take effect immediately; provided, however, that 37 section one of this act shall take effect on the one hundred twentieth 38 day after it shall have become a law. Effective immediately, the addi- 39 tion, amendment and/or repeal of any rule or regulation necessary for 40 the implementation of section one of this act on its effective date are 41 authorized and directed to be made and completed on or before such 42 effective date.